Complete response as prognostic marker of prolonged survival in metastatic melanoma

Complete response as prognostic marker of prolonged survival in metastatic melanoma

Saved in:

Bibliographic Details
Main Authors:	D. Bafaloukos, A. Molfeta, I. Gazouli, E. Chatzichristou, A. Bousboukea, A. Tarampikou, A. Giorgali, Z. Saridaki, G. Samonis
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	EJC Skin Cancer
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772611824001368
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Novel Prognostic Markers for Skin Cutaneous Melanoma
by: Zhang Y, et al.
Published: (2024-11-01)

Prolonged Remission in Metastatic Ano‐Rectal Malignant Melanoma With Single Agent Temozolomide
by: Anusha Mruthyunjaya Swamy, et al.
Published: (2025-01-01)

Evaluation of S100A8/A9 and neutrophils as prognostic markers in metastatic melanoma patients under immune-checkpoint inhibition
by: Yasmin F Melzer, et al.
Published: (2025-02-01)

Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma
by: Mario Sznol, et al.
Published: (2020-05-01)

Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic Melanoma Patient with BRAF V600K Mutation
by: K. Sahadudheen, et al.
Published: (2016-01-01)

Prolonged Survival following Repetitive Stereotactic Radiosurgery in a Patient with Intracranial Metastatic Renal Cell Carcinoma
by: Ethan A. Ferrel, et al.
Published: (2015-01-01)

Ipilimumab, a Promising Immunotherapy with Increased Overall Survival in Metastatic Melanoma?
by: Gérald E. Piérard, et al.
Published: (2012-01-01)

Evolving impact of long-term survival results on metastatic melanoma treatment
by: Olivier Michielin, et al.
Published: (2020-10-01)

Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma
by: Ileana S Mauldin, et al.
Published: (2021-06-01)

Interferon-gamma signature as prognostic and predictive marker in macroscopic stage III melanoma
by: Annegien Broeks, et al.
Published: (2024-04-01)

Metastatic heart lesion in disseminated melanoma
by: G. G. Hubulava, et al.
Published: (2024-10-01)

From Melanocyte to Malignant Metastatic Melanoma
by: Prashiela Manga, et al.
Published: (2010-01-01)

Retrospective Analysis of Rechallenge with Ipilimumab in Patients with Metastatic Melanoma
by: A. A. Formozo, et al.
Published: (2021-01-01)

A Novel 8-Gene Prognostic Signature for Survival Prediction of Uveal Melanoma
by: Zhongjun Tang, et al.
Published: (2021-01-01)

Prognostic value and immune infiltration of a tumor microenvironment-related PTPN6 in metastatic melanoma
by: Rongyao Sun, et al.
Published: (2024-12-01)

Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomas
by: Jin Xu, et al.
Published: (2024-11-01)

Inflammatory Markers as Prognostic Factors of Survival in Patients Affected by Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
by: A. Rebonato, et al.
Published: (2017-01-01)

Neural recordings can differentiate between spontaneously metastasizing melanomas and melanomas with low metastatic potential.
by: Jay Shiralkar, et al.
Published: (2024-01-01)

Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy
by: Dirk Schadendorf, et al.
Published: (2020-10-01)

From Melanocyte to Metastatic Malignant Melanoma
by: Bizhan Bandarchi, et al.
Published: (2010-01-01)

Progress in immunotherapy for brain metastatic melanoma
by: Shicheng Zheng, et al.
Published: (2025-01-01)

Surgical treatment of cardiac metastatic melanoma
by: Robert Kwinta, et al.
Published: (2024-08-01)

Marital Status and Survival in Patients Diagnosed with Melanoma
by: J. A. Maas, et al.
Published: (2020-01-01)

Durable complete response after combined treatment with tumor-infiltrating lymphocytes and oncolytic adenovirus (TILT-123) in a patient with metastatic mucosal melanoma
by: T.J. Monberg, et al.
Published: (2024-12-01)

Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study
by: Nargiz Majidova, et al.
Published: (2025-01-01)

Plasma protein dynamics during ipilimumab treatment in metastatic melanoma: associations with tumor response, adverse events and survival
by: Ragnhild Reehorst Lereim, et al.
Published: (2025-12-01)

Title: Survival Analysis of Patients with Non-Cutaneous Metastatic Melanoma Treated in a Reference Center in Northeast Mexico
by: T. Guel, et al.
Published: (2024-01-01)

Comparing the associations between host and tumor factors with survival outcomes with anti‐PD‐1 immunotherapy in metastatic melanoma
by: Kim Koczka, et al.
Published: (2023-02-01)

Correction: Neural recordings can differentiate between spontaneously metastasizing melanomas and melanomas with low metastatic potential.
by: Jay Shiralkar, et al.
Published: (2025-01-01)

A case of cutaneous melanoma metastatic to the ciliary body and choroid with complete regression via systemic dual checkpoint inhibitor therapy
by: Ansam I. Qaddoumi, et al.
Published: (2025-01-01)

Locally Advanced and Metastatic Pancreatic Cancer: Survival analysis and prognostic factors in a case series
by: Paloma Porto Amorim, et al.
Published: (2020-01-01)

Systemic therapy of skin metastatic melanoma with BRAF gene mutation
by: Yu. S. Shakh-Paronyants, et al.
Published: (2023-03-01)

Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3‐year survival update and multi‐omics analysis
by: Jie Dai, et al.
Published: (2025-01-01)

Prognostic value of immune biomarkers in melanoma loco-regional metastases.
by: Emilia Hugdahl, et al.
Published: (2025-01-01)

A clinical case of small intestinal intussusception caused by metastatic melanoma
by: S. M. Zavhorodnii, et al.
Published: (2023-06-01)

Cyclooxygenase 2 (COX2) and Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Are Stage-Dependent Prognostic Markers of Malignant Melanoma
by: Stefanie Meyer, et al.
Published: (2010-01-01)

Markers of metastatic colorectal cancer
by: Piotr Myśliwiec, et al.
Published: (2019-05-01)

18F-FDG PET/CT assessment of metabolic tumor burden predicts survival in patients with metastatic posterior uveal melanoma
by: Tine Gadegaard Hindso, et al.
Published: (2025-02-01)

Patient treatment preferences in unresectable/metastatic BRAF-mutated melanoma: a qualitative study
by: T. Amaral, et al.
Published: (2024-01-01)

HLA-G Dimers in the Prolongation of Kidney Allograft Survival
by: Maureen Ezeakile, et al.
Published: (2014-01-01)